HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jacqueline French Selected Research

Vigabatrin

10/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
10/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
7/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
7/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jacqueline French Research Topics

Disease

23Epilepsy (Aura)
11/2021 - 12/2006
20Seizures (Absence Seizure)
11/2021 - 06/2003
9Partial Epilepsies (Epilepsy, Partial)
11/2021 - 03/2014
5Generalized Epilepsy
10/2018 - 03/2011
5Drug Resistant Epilepsy
03/2011 - 02/2005
3Inflammation (Inflammations)
04/2020 - 01/2011
2Juvenile Myoclonic Epilepsy
10/2018 - 07/2018
2Absence Epilepsy (Childhood Absence Epilepsy)
10/2018 - 07/2018
2Neuroinflammatory Diseases
01/2016 - 01/2013
1Autoimmune Diseases of the Nervous System
11/2021
1Infertility (Sterility)
01/2019
1Reflex Epilepsy (Photosensitive Epilepsy)
01/2019
1Lennox Gastaut Syndrome
10/2018
1Fatigue
01/2014
1Sleepiness
01/2014
1Dizziness (Lightheadedness)
01/2014
1Autism Spectrum Disorder
09/2013
1Aseptic Meningitis
08/2012
1Idiopathic Generalized Epilepsy
03/2012
1Status Epilepticus (Complex Partial Status Epilepticus)
04/2011
1Congenital Abnormalities (Deformity)
11/2007
1Temporal Lobe Epilepsy
06/2003

Drug/Important Bio-Agent (IBA)

21Anticonvulsants (Antiepileptic Drugs)IBA
01/2021 - 06/2003
12Pharmaceutical PreparationsIBA
04/2020 - 08/2005
7Pregabalin (Lyrica)FDA Link
10/2018 - 01/2014
6Levetiracetam (Keppra)FDA LinkGeneric
10/2018 - 02/2005
5LacosamideFDA Link
10/2018 - 07/2014
5perampanelIBA
10/2018 - 03/2014
5Lamotrigine (Lamictal)FDA LinkGeneric
10/2018 - 08/2012
4Topiramate (Topamax)FDA LinkGeneric
10/2018 - 07/2018
4rufinamideFDA Link
10/2018 - 07/2018
4ezogabine (retigabine)IBA
10/2018 - 07/2018
4eslicarbazepineIBA
10/2018 - 07/2018
4VigabatrinFDA Link
10/2018 - 07/2018
4Zonisamide (Zonegran)FDA LinkGeneric
10/2018 - 07/2018
4Clobazam (HR 376)IBA
10/2018 - 07/2018
4Oxcarbazepine (Trileptal)FDA LinkGeneric
10/2018 - 07/2018
3Gabapentin (Neurontin)FDA LinkGeneric
10/2018 - 09/2016
2gamma-Aminobutyric Acid (GABA)IBA
04/2020 - 01/2019
2Felbamate (Felbatol)FDA Link
10/2018 - 07/2018
2Valproic Acid (Depakote)FDA LinkGeneric
10/2018 - 07/2018
2Tiagabine (Gabitril)FDA Link
10/2018 - 07/2018
2Ethosuximide (Zarontin)FDA LinkGeneric
10/2018 - 07/2018
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
10/2011 - 04/2011
2InterleukinsIBA
10/2011 - 04/2011
1AutoantibodiesIBA
11/2021
1Antisense OligonucleotidesIBA
04/2020
1Potassium Channels (Potassium Channel)IBA
04/2020
1MTOR InhibitorsIBA
04/2020
1Investigational DrugsIBA
04/2020
1T-Type Calcium Channels (T-Type Calcium Channel)IBA
04/2020
1PF-06372865IBA
01/2019
1Contraceptive Agents (Contraceptives)IBA
01/2019
1BenzodiazepinesIBA
01/2019
1CannabidiolIBA
06/2014
1CannabinoidsIBA
06/2014
1Delayed-Action PreparationsIBA
01/2014
1Prostaglandins BIBA
01/2014
1Proteins (Proteins, Gene)FDA Link
09/2013
1DNA (Deoxyribonucleic Acid)IBA
08/2013
1PK 11195 (PK11195)IBA
01/2013
1Immunoglobulin E (IgE)IBA
03/2012
1LigandsIBA
10/2011
1Toll-Like Receptors (Toll-Like Receptor)IBA
10/2011
1EnzymesIBA
04/2011
1Caspase 1 (ICE Protease)IBA
04/2011
1IceIBA
04/2011
1belnacasanIBA
04/2011

Therapy/Procedure

9Therapeutics
04/2020 - 06/2003
2Deep Brain Stimulation
03/2015 - 05/2010
1Precision Medicine
04/2020
1Contraception (Birth Control)
01/2019